Replies to post #67805 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

I will start to get excited when we are back up to $6 and above, which is around a $300 million valuation, which is the minimum of where we should be as a Phase III company with a solid pipeline and $500 million NEO with Amgen.